Osterrieder N - Search Results

1

A Point Mutation in a Herpesvirus Co-Determines Neuropathogenicity and Viral Shedding.

Franz M, Goodman LB, Van de Walle GR, Osterrieder N, Greenwood AD. Franz M, et al. Among authors: osterrieder n. Viruses. 2017 Jan 10;9(1):6. doi: 10.3390/v9010006. Viruses. 2017. PMID: 28075374 Free PMC article.

2

Potential of equine herpesvirus 1 as a vector for immunization.

Trapp S, von Einem J, Hofmann H, Köstler J, Wild J, Wagner R, Beer M, Osterrieder N. Trapp S, et al. Among authors: osterrieder n. J Virol. 2005 May;79(9):5445-54. doi: 10.1128/JVI.79.9.5445-5454.2005. J Virol. 2005. PMID: 15827159 Free PMC article.

3

Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?

Rosas CT, Goodman LB, von Einem J, Osterrieder N. Rosas CT, et al. Among authors: osterrieder n. Expert Rev Vaccines. 2006 Feb;5(1):119-31. doi: 10.1586/14760584.5.1.119. Expert Rev Vaccines. 2006. PMID: 16451114 Free article. Review.

4

Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).

Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N. Goodman LB, et al. Among authors: osterrieder n. Vaccine. 2006 Apr 24;24(17):3636-45. doi: 10.1016/j.vaccine.2006.01.062. Epub 2006 Feb 13. Vaccine. 2006. PMID: 16513225

5

Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).

Rosas CT, Tischer BK, Perkins GA, Wagner B, Goodman LB, Osterrieder N. Rosas CT, et al. Among authors: osterrieder n. Virus Res. 2007 Apr;125(1):69-78. doi: 10.1016/j.virusres.2006.12.009. Epub 2007 Jan 22. Virus Res. 2007. PMID: 17241683

6

In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).

von Einem J, Smith PM, Van de Walle GR, O'Callaghan DJ, Osterrieder N. von Einem J, et al. Among authors: osterrieder n. Virology. 2007 May 25;362(1):151-62. doi: 10.1016/j.virol.2006.12.008. Epub 2007 Jan 23. Virology. 2007. PMID: 17250864 Free article.

7

Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo.

Van de Walle GR, May ML, Sukhumavasi W, von Einem J, Osterrieder N. Van de Walle GR, et al. Among authors: osterrieder n. J Immunol. 2007 Sep 15;179(6):4161-9. doi: 10.4049/jimmunol.179.6.4161. J Immunol. 2007. PMID: 17785855

8

A point mutation in a herpesvirus polymerase determines neuropathogenicity.

Goodman LB, Loregian A, Perkins GA, Nugent J, Buckles EL, Mercorelli B, Kydd JH, Palù G, Smith KC, Osterrieder N, Davis-Poynter N. Goodman LB, et al. Among authors: osterrieder n. PLoS Pathog. 2007 Nov;3(11):e160. doi: 10.1371/journal.ppat.0030160. PLoS Pathog. 2007. PMID: 17997600 Free PMC article.

9

CCL3 and viral chemokine-binding protein gg modulate pulmonary inflammation and virus replication during equine herpesvirus 1 infection.

Van de Walle GR, Sakamoto K, Osterrieder N. Van de Walle GR, et al. Among authors: osterrieder n. J Virol. 2008 Feb;82(4):1714-22. doi: 10.1128/JVI.02137-07. Epub 2007 Dec 12. J Virol. 2008. PMID: 18077722 Free PMC article.

10

Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection.

Van de Walle GR, Jarosinski KW, Osterrieder N. Van de Walle GR, et al. Among authors: osterrieder n. J Virol. 2008 Jul;82(13):6090-7. doi: 10.1128/JVI.00098-08. Epub 2008 Apr 2. J Virol. 2008. PMID: 18385255 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters